netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.02.01  Expand sub section  Antipsychotic Drugs
04.02.01  Expand sub section  First-Generation Antipsychotic Drugs
Chlorpromazine
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice Tablets
Oral solution
Injection 
Haloperidol
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice Tablets
Capsules
Oral liquid
Injection 
Sulpiride
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice Tablets
Oral solution 
   
Flupentixol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets 
   
Levomepromazine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Injection 
   
Pericyazine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets 
   
Perphenazine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets 
   
Pimozide
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets 
   
Promazine Hydrochloride
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Oral solution

note Only licensed for agitation 
   
Trifluoperazine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Oral solution 5mg/5mL
Syrup 1mg/5mL 
   
Zuclopenthixol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets 
   
Zuclopenthixol Acetate injection (Clopixol Acuphase®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
04.02.01  Expand sub section  Second-Generation Antipsychotic Drugs
Olanzapine
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Amber
Tablets
Orodispersible tablets 
Quetiapine
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Amber
Tablets
M/R tablets
 
Risperidone
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Amber
Tablets
Orodispersible tablets
Liquid 
Amisulpride
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Tablets
Oral solution

Red Traffic Light RED when prescribed for new patients with dementia or other unlicensed indications 
   
Aripiprazole
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Tablets
Orodispersible tablets
Oral solution
Injection (IM)

Red Traffic Light RED when prescribed for new patients with dementia or other unlicensed indications  
Link  NICE TA213: Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years
Link  NICE TA292: Aripiprazole for manic episodes in adolescents with bipolar I disorder
   
Clozapine (Clozaril®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
Clozapine is only indicated for treatment resistant schizophrenia.
Prescribers, pharmacies and patients must be registered with the relevant supplier’s patient monitoring service. 
Link  MHRA Safety Update: Potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
   
Clozapine (Zaponex®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
Clozapine is only indicated for treatment resistant schizophrenia.
Prescribers, pharmacies and patients must be registered with the relevant supplier’s patient monitoring service. 
Link  MHRA Safety Update: Potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
   
 ....
 Non Formulary Items
Benperidol  (Anquil®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Clozapine  (Denzapine®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fluphenazine Hydrochloride  (Moditen®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Haloperidol  (Dozic®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Haloperidol  (Haldol®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Haloperidol  (Serenace®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lurasidone  (Latuda®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Paliperidone

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Amber
 
Prochlorperazine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sulpiride  (Dolmatil®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sulpiride  (Sulpor®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Trifluoperazine  (Stelazine®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Drugs designated amber are suitable for shared care arrangements under a shared care protocol. Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. Alternatively primary care may initiate under the supervision of secondary care if this option is given in the shared care document. It is recommended that shared care arrangements should be drawn up following local discussion and agreement by prescribing parties.   

Black

These products have been reviewed by the GM Joint Formulary Group and have been deemed not suitable for prescribing for adults in primary or secondary care within Greater Manchester. These decisions have been made on the basis of safety, efficacy and cost-effectiveness of the products.  

Green

Not used   

Green 1

Drugs designated green1 are suitable for initiation and ongoing prescribing within primary care.   

Green 2

Drugs designated green2 can be initiated by primary care following written or verbal advice from a specialist and then be subsequently safely prescribed in primary care with little or no monitoring required.  

Green 3

Drugs designated green3 are suitable for on-going prescribing within primary care after specialist initiation and an initial review (unless specified) in secondary care. Little or no monitoring is required.  

Grey

Not suitable for routine prescribing but may be suitable for a defined patient population. Whilst prescribers should think very carefully before prescribing or recommending any of the products on the grey list, there may be exceptional instances when the use of one of these products is necessary for a particular patient.   

Red

Drugs designated red are considered to be specialist medicines and prescribing responsibility for these medicines should normally remain with the consultant or specialist clinician. These drugs should not be initiated or prescribed in primary care. It is recommended that the supply of these specialist medicines should be organised via the hospital pharmacy, this may include arranging for supply via a home care company.   

netFormulary